Advertisement

Index by Author

March 1997; 46 (3)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abboud, H E

    • Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes March 1997 46:473-480; doi:10.2337/diabetes.46.3.473

  2. Abboud, S L

    • Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes March 1997 46:473-480; doi:10.2337/diabetes.46.3.473

  3. Al-Barazanji, K

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  4. Albu, J B

    • Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes March 1997 46:456-462; doi:10.2337/diabetes.46.3.456

  5. Alzaid, A

    • Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421

  6. Andersen, C B

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494

  7. Antonucci, T K

    • Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433

  8. Araki, E

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  9. Arch, J R

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  10. Arner, P

    • Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes March 1997 46:451-455; doi:10.2337/diabetes.46.3.451

  11. Assimacopoulos-Jeannet, F

    • Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes March 1997 46:393-400; doi:10.2337/diabetes.46.3.393

  12. Atkinson, P

    • Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes March 1997 46:372-378; doi:10.2337/diabetes.46.3.372

  13. Atkinson, R L

    • Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes March 1997 46:451-455; doi:10.2337/diabetes.46.3.451

B

  1. Bagdade, J D

    • Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM. Diabetes March 1997 46:414-420; doi:10.2337/diabetes.46.3.414

  2. Basu, A

    • Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421

  3. Beattie, G M

    • Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes March 1997 46:519-523; doi:10.2337/diabetes.46.3.519

  4. Behme, M T

    • Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes March 1997 46:372-378; doi:10.2337/diabetes.46.3.372

  5. Bell, G I

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  6. Bettini, F

    • Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421

  7. Bing, C

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  8. Björnholm, M

    • Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes March 1997 46:524-527; doi:10.2337/diabetes.46.3.524

  9. Boelskifte, S

    • Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes March 1997 46:481-487; doi:10.2337/diabetes.46.3.481

  10. Boriraj, V V

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  11. Brun, T

    • Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes March 1997 46:393-400; doi:10.2337/diabetes.46.3.393

  12. Buckingham, R

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  13. Burkart, V

    • MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice. Diabetes March 1997 46:379-385; doi:10.2337/diabetes.46.3.379

  14. Burns, D K

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

C

  1. Caumo, A

    • Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421

  2. Chiasson, J L

    • Insulin lispro in CSII: results of a double-blind crossover study. Diabetes March 1997 46:440-443; doi:10.2337/diabetes.46.3.440

  3. Chua, S C, Jr

    • Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes March 1997 46:513-518; doi:10.2337/diabetes.46.3.513

  4. Cirulli, V

    • Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes March 1997 46:519-523; doi:10.2337/diabetes.46.3.519

  5. Clausen, J O

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494
    • Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes March 1997 46:508-512; doi:10.2337/diabetes.46.3.508

  6. Cobelli, C

    • Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421

  7. Corkey, B E

    • Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes March 1997 46:393-400; doi:10.2337/diabetes.46.3.393

  8. Crowe, J H

    • Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes March 1997 46:519-523; doi:10.2337/diabetes.46.3.519

D

  1. Digby, J E

    • Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes March 1997 46:342-347; doi:10.2337/diabetes.46.3.342

  2. Donis-Keller, H

    • Mapping novel pancreatic islet genes to human chromosomes. Diabetes March 1997 46:386-392; doi:10.2337/diabetes.46.3.386

  3. Driscoll, J H

    • Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433

  4. Dryden, S

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  5. Dupré, J

    • Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes March 1997 46:372-378; doi:10.2337/diabetes.46.3.372

E

  1. Echwald, S M

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494
    • Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes March 1997 46:508-512; doi:10.2337/diabetes.46.3.508

  2. Eckel, R H

    • Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM. Diabetes March 1997 46:414-420; doi:10.2337/diabetes.46.3.414

  3. Elbein, S C

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  4. Esser, V

    • Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes March 1997 46:408-413; doi:10.2337/diabetes.46.3.408

F

  1. Faja, B W

    • Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433

  2. Faustman, D

    • New monoclonal antibody diagnostic reagents for type I diabetes: differential lymphocyte surface antigen expression related to disease. Diabetes March 1997 46:363-371; doi:10.2337/diabetes.46.3.363

  3. Ferrer, J

    • Mapping novel pancreatic islet genes to human chromosomes. Diabetes March 1997 46:386-392; doi:10.2337/diabetes.46.3.386
    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  4. Frager, D H

    • Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes March 1997 46:456-462; doi:10.2337/diabetes.46.3.456

  5. Fukuda, K

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

  6. Furukawa, N

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  7. Fu, Y

    • New monoclonal antibody diagnostic reagents for type I diabetes: differential lymphocyte surface antigen expression related to disease. Diabetes March 1997 46:363-371; doi:10.2337/diabetes.46.3.363

G

  1. Ganaway, E

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  2. Garvey, W T

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  3. Gelisio, A

    • Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421

  4. Ghazzi, M N

    • Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433

  5. Gillison, S L

    • The alpha2-adrenergic receptor is more effective than the galanin receptor in activating G-proteins in RINm5F beta-cell membranes. Diabetes March 1997 46:401-407; doi:10.2337/diabetes.46.3.401

  6. Gloyer, I S

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  7. Guan, J

    • Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes March 1997 46:372-378; doi:10.2337/diabetes.46.3.372

H

  1. Hamacher, L L

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  2. Hampe, C L

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  3. Hansen, L

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494
    • Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes March 1997 46:508-512; doi:10.2337/diabetes.46.3.508

  4. Hansen, T

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494
    • Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes March 1997 46:508-512; doi:10.2337/diabetes.46.3.508

  5. Hayek, A

    • Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes March 1997 46:519-523; doi:10.2337/diabetes.46.3.519

  6. Heinecke, J W

    • The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes March 1997 46:327-334; doi:10.2337/diabetes.46.3.327

  7. Henry, R R

    • Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM. Diabetes March 1997 46:414-420; doi:10.2337/diabetes.46.3.414

  8. Hibino, M

    • Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes March 1997 46:348-353; doi:10.2337/diabetes.46.3.348

  9. Higashi, T

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  10. Hirose, H

    • Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes March 1997 46:408-413; doi:10.2337/diabetes.46.3.408

  11. Horiuchi, S

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  12. Hotamisligil, G S

    • Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes March 1997 46:451-455; doi:10.2337/diabetes.46.3.451

  13. Huang, S M

    • Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433

I

  1. Ikeda, K

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  2. Inagaki, N

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  3. Inoue, H

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  4. Ito, T

    • Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes March 1997 46:348-353; doi:10.2337/diabetes.46.3.348

J

  1. Jensen, B R

    • Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes March 1997 46:481-487; doi:10.2337/diabetes.46.3.481

  2. Jinnouchi, Y

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  3. Johnson, J A

    • Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes March 1997 46:456-462; doi:10.2337/diabetes.46.3.456

K

  1. Kaisaki, P J

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  2. Kaneko, K

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  3. Kanzaki, T

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  4. Kawakami, K

    • Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes March 1997 46:348-353; doi:10.2337/diabetes.46.3.348

  5. Kawano, Y

    • Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes March 1997 46:524-527; doi:10.2337/diabetes.46.3.524

  6. Kelley, D E

    • Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM. Diabetes March 1997 46:414-420; doi:10.2337/diabetes.46.3.414

  7. Kennedy, A

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  8. Kerner, W

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  9. Kishikawa, H

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  10. Kiyomoto, H

    • Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes March 1997 46:473-480; doi:10.2337/diabetes.46.3.473

  11. Kolb, H

    • MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice. Diabetes March 1997 46:379-385; doi:10.2337/diabetes.46.3.379

  12. Kume, S

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

L

  1. Ledermann, H M

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  2. Lee, Y

    • Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes March 1997 46:408-413; doi:10.2337/diabetes.46.3.408

  3. Lehtihet, M

    • Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes March 1997 46:524-527; doi:10.2337/diabetes.46.3.524

  4. Leibel, R L

    • Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes March 1997 46:513-518; doi:10.2337/diabetes.46.3.513

  5. Lenhard, J M

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  6. Lindner, T

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  7. Liu, S M

    • Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes March 1997 46:513-518; doi:10.2337/diabetes.46.3.513

  8. Lopez, A D

    • Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes March 1997 46:519-523; doi:10.2337/diabetes.46.3.519

M

  1. Maianu, L

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  2. Matsuda, K

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  3. Matsui, H

    • Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes March 1997 46:348-353; doi:10.2337/diabetes.46.3.348

  4. McBay, D L

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  5. McGarry, J D

    • Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes March 1997 46:408-413; doi:10.2337/diabetes.46.3.408

  6. McHale, M T

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  7. Meincke, G

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  8. Menzel, R

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  9. Menzel, S

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  10. Millns, H

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  11. Montague, C T

    • Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes March 1997 46:342-347; doi:10.2337/diabetes.46.3.342

  12. Morisaki, N

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  13. Mossakowaska, D E

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  14. Motoshima, H

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  15. Mueckler, M

    • Mapping novel pancreatic islet genes to human chromosomes. Diabetes March 1997 46:386-392; doi:10.2337/diabetes.46.3.386

  16. Murphy, L

    • Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes March 1997 46:456-462; doi:10.2337/diabetes.46.3.456

N

  1. Neville, W A

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  2. Nicolson, M

    • Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes March 1997 46:513-518; doi:10.2337/diabetes.46.3.513

  3. Nielsen, F S

    • Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes March 1997 46:481-487; doi:10.2337/diabetes.46.3.481

O

  1. O'Rahilly, S

    • Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes March 1997 46:342-347; doi:10.2337/diabetes.46.3.342

  2. Oda, N

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  3. Okada, N

    • Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes March 1997 46:513-518; doi:10.2337/diabetes.46.3.513

  4. Okumura, K

    • Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes March 1997 46:348-353; doi:10.2337/diabetes.46.3.348

  5. Onaya, T

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

  6. Owens, D

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494

  7. Ozaki, Y

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

P

  1. Park, I S

    • Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes March 1997 46:473-480; doi:10.2337/diabetes.46.3.473

  2. Parving, H H

    • Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes March 1997 46:481-487; doi:10.2337/diabetes.46.3.481

  3. Pedersen, O

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494
    • Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes March 1997 46:508-512; doi:10.2337/diabetes.46.3.508

  4. Perez, J E

    • Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433

  5. Permutt, M A

    • Mapping novel pancreatic islet genes to human chromosomes. Diabetes March 1997 46:386-392; doi:10.2337/diabetes.46.3.386
    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  6. Petzold, C

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  7. Pickavance, L

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  8. Pinies, J A

    • New monoclonal antibody diagnostic reagents for type I diabetes: differential lymphocyte surface antigen expression related to disease. Diabetes March 1997 46:363-371; doi:10.2337/diabetes.46.3.363

  9. Pi-Sunyer, F X

    • Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes March 1997 46:456-462; doi:10.2337/diabetes.46.3.456

  10. Prentki, M

    • Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes March 1997 46:393-400; doi:10.2337/diabetes.46.3.393

  11. Prins, J B

    • Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes March 1997 46:342-347; doi:10.2337/diabetes.46.3.342

R

  1. Radons, J

    • MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice. Diabetes March 1997 46:379-385; doi:10.2337/diabetes.46.3.379

  2. Rauvala, H

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  3. Ricordi, C

    • Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes March 1997 46:519-523; doi:10.2337/diabetes.46.3.519

  4. Ritter, M C

    • Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM. Diabetes March 1997 46:414-420; doi:10.2337/diabetes.46.3.414

  5. Rizza, R A

    • Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes March 1997 46:421-432; doi:10.2337/diabetes.46.3.421

  6. Rjasanowski, I

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  7. Rossing, P

    • Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes March 1997 46:481-487; doi:10.2337/diabetes.46.3.481

S

  1. Sachse, G

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  2. Sahm, J

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  3. Saishoji, T

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  4. Sakurada, K

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

  5. Sanders, L

    • Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes March 1997 46:342-347; doi:10.2337/diabetes.46.3.342

  6. Sano, H

    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  7. Sasaki, Y

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

  8. Satoh, K

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

  9. Schmechel, H

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  10. Schoor, K D

    • Mapping novel pancreatic islet genes to human chromosomes. Diabetes March 1997 46:386-392; doi:10.2337/diabetes.46.3.386

  11. Schulze, J

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  12. Seino, S

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  13. Semenkovich, C F

    • The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes March 1997 46:327-334; doi:10.2337/diabetes.46.3.327

  14. Seto, M

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

  15. Sharp, G W

    • The alpha2-adrenergic receptor is more effective than the galanin receptor in activating G-proteins in RINm5F beta-cell membranes. Diabetes March 1997 46:401-407; doi:10.2337/diabetes.46.3.401

  16. Shichiri, M

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354
    • The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes March 1997 46:463-472; doi:10.2337/diabetes.46.3.463

  17. Spiegelman, B M

    • Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes March 1997 46:451-455; doi:10.2337/diabetes.46.3.451

  18. Strack, T

    • Insulin lispro in CSII: results of a double-blind crossover study. Diabetes March 1997 46:440-443; doi:10.2337/diabetes.46.3.440

  19. Straub, S G

    • The alpha2-adrenergic receptor is more effective than the galanin receptor in activating G-proteins in RINm5F beta-cell membranes. Diabetes March 1997 46:401-407; doi:10.2337/diabetes.46.3.401

  20. Suarez, B K

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

T

  1. Taddayon, M

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  2. Tarnow, L

    • Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes March 1997 46:481-487; doi:10.2337/diabetes.46.3.481

  3. Tawata, M

    • Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes March 1997 46:488-493; doi:10.2337/diabetes.46.3.488

  4. Thomas, M E

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  5. Tildesley, H

    • Insulin lispro in CSII: results of a double-blind crossover study. Diabetes March 1997 46:440-443; doi:10.2337/diabetes.46.3.440

  6. Toki, Y

    • Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes March 1997 46:348-353; doi:10.2337/diabetes.46.3.348

  7. Trayhurn, P

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  8. Tsui, E

    • Insulin lispro in CSII: results of a double-blind crossover study. Diabetes March 1997 46:440-443; doi:10.2337/diabetes.46.3.440

  9. Tsuruzoe, K

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  10. Turner, R C

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502
    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

U

  1. Unger, R H

    • Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes March 1997 46:408-413; doi:10.2337/diabetes.46.3.408

  2. Urhammer, S A

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494
    • Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes March 1997 46:508-512; doi:10.2337/diabetes.46.3.508

V

  1. Vazquez, J A

    • New monoclonal antibody diagnostic reagents for type I diabetes: differential lymphocyte surface antigen expression related to disease. Diabetes March 1997 46:363-371; doi:10.2337/diabetes.46.3.363

  2. Vestergaard, H

    • Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes March 1997 46:494-501; doi:10.2337/diabetes.46.3.494

W

  1. Wallace, P

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  2. Wang, Q

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  3. Wang, X M

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  4. Warren-Perry, M

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  5. Wasson, J

    • Mapping novel pancreatic islet genes to human chromosomes. Diabetes March 1997 46:386-392; doi:10.2337/diabetes.46.3.386

  6. Whitcomb, R W

    • Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes March 1997 46:433-439; doi:10.2337/diabetes.46.3.433

  7. Williams, G

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  8. Wilson, S

    • Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes March 1997 46:335-341; doi:10.2337/diabetes.46.3.335

  9. Wu-Peng, X S

    • Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes March 1997 46:513-518; doi:10.2337/diabetes.46.3.513

Y

  1. Yamagata, K

    • Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes March 1997 46:528-535; doi:10.2337/diabetes.46.3.528

  2. Yarnall, D P

    • Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes March 1997 46:444-450; doi:10.2337/diabetes.46.3.444

  3. Yoshimura, R

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

  4. Yoshizato, K

    • Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells. Diabetes March 1997 46:354-362; doi:10.2337/diabetes.46.3.354

Z

  1. Zhang, Y

    • Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes March 1997 46:502-507; doi:10.2337/diabetes.46.3.502

  2. Zhong, R

    • Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes March 1997 46:372-378; doi:10.2337/diabetes.46.3.372

  3. Zhou, Y T

    • Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes March 1997 46:408-413; doi:10.2337/diabetes.46.3.408

  4. Zierath, J R

    • Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes March 1997 46:524-527; doi:10.2337/diabetes.46.3.524

  5. Zinman, B

    • Insulin lispro in CSII: results of a double-blind crossover study. Diabetes March 1997 46:440-443; doi:10.2337/diabetes.46.3.440

  6. Zucker, P F

    • Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes March 1997 46:372-378; doi:10.2337/diabetes.46.3.372

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement